ClinicalThought

Share

Program Content

Activities

  • CDK4/6i and PI3Ki in HR+/HER2-
    CDK4/6 and PI3K Inhibitors for HR+/HER2- Breast Cancer in the Clinic Today: Thoughts From the Experts
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 23, 2021

    Expires: March 22, 2022

  • Abemaciclib in EBC
    What to Know About the New Approval for Abemaciclib in Patients With Early Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 29, 2021

    Expires: November 28, 2022

Faculty

cover img faculity

Matthew P. Goetz, MD

Professor of Oncology and Pharmacology
Director, Mayo Breast Cancer SPORE
Co-PI, Womens Cancer Program
Department of Medical Oncology
Mayo Clinic
Rochester, Minnesota

cover img faculity

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

cover img faculity

Laura M. Spring, MD

Breast Medical Oncologist
Mass General Cancer Center
Harvard Medical School
Boston, Massachusetts

Supporters

Lilly

Partners

Smart Patients

ProCE Banner